Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

516 Press Releases
DateTitleCompany
06 Jan 11 Boceprevir, Merck’s Investigational Oral Hepatitis C Protease Inhibitor, Receives FDA Priority Review and EMA Accelerated Assessment Merck,
Published by
Business Wire
05 Jan 11 Merck to Hold Fourth-Quarter 2010 Sales and Earnings Conference Call on Feb. 3 Merck,
Published by
Business Wire
23 Dec 10 US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL® Merck,
Published by
Business Wire
14 Dec 10 The PATH Malaria Vaccine Initiative, Merck and NYU Langone Medical Center Collaborate to Research Potential Malaria Vaccine Merck,
Published by
Business Wire
08 Dec 10 Merck Prices $2.0 Billion Debt Offering Merck & Co. Inc.,
Published by
Business Wire
02 Dec 10 Merck to Acquire SmartCells, Inc. Merck & Co. Inc.,
Published by
Business Wire
30 Nov 10 Merck Board Elects Kenneth C. Frazier as Next CEO; Richard T. Clark to Continue as Chairman Merck,
Published by
Business Wire
29 Nov 10 Merck Reports Initial Results of Phase III Study of ISENTRESS® (raltegravir) Investigational Once-Daily Dosing in Treatment-Naïve Adult Patients Infected with HIV-1 Merck & Co. Inc.,
Published by
Business Wire
24 Nov 10 Merck Announces First-Quarter 2011 Dividend Merck & Co. Inc.,
Published by
Business Wire
22 Nov 10 Merck Serono: ASCO Highlights Erbitux Research as Major Advance for Third Year in a Row Merck Serono,
Published by
PharmiWeb.com
20 Nov 10 VYTORIN® (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease in a New 9,000-Patient Investigational Study Merck,
Published by
Business Wire
20 Nov 10 Merck Wins Another Federal FOSAMAX® (alendronate sodium) Bellwether Trial Merck & Co. Inc.,
Published by
Business Wire
18 Nov 10 FDA Advisory Committee Supports Approval of GARDASIL® for Prevention of Anal Cancer and AIN in both Men and Women Merck,
Published by
Business Wire
17 Nov 10 In Phase III Study Merck's Investigational CETP Inhibitor Anacetrapib Met Safety and Efficacy Endpoints in Patients with CHD Merck,
Published by
Business Wire
11 Nov 10 Merck and Partners Make Progress in Long-Term Commitment to End River Blindness Merck,
Published by
Business Wire
10 Nov 10 Merck Wins TEMODAR® Patent Infringement Lawsuit on Appeal Merck & Co. Inc.,
Published by
Business Wire
30 Oct 10 Merck's Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates In Treatment-Failure and Treatment-Naïve Adult Patients with Chronic Hepatitis C Genotype 1 Compared to Control Merck,
Published by
Business Wire
29 Oct 10 Merck Announces Third-Quarter 2010 Financial Results Merck & Co. Inc.,
Published by
Business Wire
22 Oct 10 In Investigational Study, ZOSTAVAX®, Merck's Shingles Vaccine, Reduced Incidence of Shingles in Adults Ages 50 to 59 by Nearly 70 Percent Merck,
Published by
Business Wire
19 Oct 10 New Data on Odanacatib, Merck’s Investigational Cathepsin-K Inhibitor for Osteoporosis, Presented at American Society for Bone and Mineral Research Annual Meeting Merck & Co. Inc.,
Published by
Business Wire
12 Oct 10 Lundbeck and Merck Sign Exclusive Commercialization Agreement for SYCREST® (asenapine) Sublingual Tablets in All Markets Outside of the United States, China and Japan Merck,
Published by
Business Wire
11 Oct 10 Surveys Highlight Advancing Confidence in Erbitux as Only Targeted Treatment to Increase Survival and Potential for Cure in Head and Neck Cancer Merck Serono,
Published by
PharmiWeb.com
11 Oct 10 Surveys Highlight Advancing Confidence in Erbitux as Only Targeted Treatment to Increase Survival and Potential for Cure in Head and Neck Cancer Merck Serono,
Published by
Business Wire
05 Oct 10 Merck to Appeal Reduced Jury Verdict in Federal FOSAMAX® (alendronate sodium) Case Merck & Co. Inc.,
Published by
Business Wire
04 Oct 10 New Data for Erbitux in Prevalent Cancers to Be Revealed at ESMO Merck Serono,
Published by
Business Wire
01 Oct 10 Merck Announces Pivotal Phase III Data for Boceprevir will be Presented at the American Association for the Study of Liver Diseases 2010 Annual Meeting Merck,
Published by
Business Wire
01 Oct 10 Merck to Hold Third-Quarter 2010 Sales and Earnings Conference Call on Oct. 29 Merck & Co. Inc.,
Published by
Business Wire
01 Oct 10 Merck to Appeal Verdict in Massachusetts Medicaid Case Merck & Co. Inc.,
Published by
Business Wire
29 Sep 10 ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) Awarded Prix Galien USA 2010 Top Honor Merck,
Published by
Business Wire
22 Sep 10 Merck Significantly Expands its Patient Assistance Program Offerings to Provide Access to More Medicines for People in Need Merck,
Published by
Business Wire
Advertising